Ignite Creation Date:
2025-12-24 @ 6:33 PM
Ignite Modification Date:
2026-01-22 @ 11:33 AM
Study NCT ID:
NCT00452257
Status:
COMPLETED
Last Update Posted:
2009-03-19
First Post:
2007-03-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Enzastaurin in Patients With Leukemia
Sponsor:
Eli Lilly and Company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
10724
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Chief Medical Officer
Old Organization:
Eli Lilly